Periodontal Treatment in Cancer Patients: An Interdisciplinary Approach

Overview

Journal Curr Oral Health Rep

Specialty Dentistry

Date 2018 Jun 19

PMID 29910997

Citations 5

Authors

A M Decker

L S Taichman

N J DSilva

R S Taichman

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Dental care is an essential component in the comprehensive treatment for the cancer patient. As such, a review of the literature was completed to determine the relationships between periodontal and dental care in the cancer patient and provide strategic suggestions.

Recent Findings: Periodontal treatment must be personalized depending on the patient's current oral health status, systemic status, and progress in treatment. Oral mucositis, periodontal status, and osteonecrosis of the jaw (ONJ) remain periodontal concerns in the cancer patient. Contributing factors of ONJ include root amputation (OR= 6.64), extraction of a single tooth (OR=3.7), severe tooth mobility (OR = 3.60), and unclosed wound (OR = 2.51).

Summary: Preventive maintenance, oral hygiene instruction, use of fluoride and chlorhexidine are all important therapeutic strategies. If extractions are required in patients who have received bone modifying drug infusions, flap management and primary wound closure is needed to reduce the risk of complications.

Citing Articles

Radiation effects in head and neck and role of hyperbaric oxygen therapy: An adjunct to management.

Kumar V, Sharma V, Pandey S, Pal U Natl J Maxillofac Surg. 2024; 15(2):220-227.

PMID: 39234127 PMC: 11371294. DOI: 10.4103/njms.njms_185_23.

Chemotherapy-induced oral mucositis: hierarchical analysis of recurrence factors.

de Macedo T, de Melo M, Ferreira A, da Silva-Selva E, Godoy G, Caldas Junior A Eur Arch Paediatr Dent. 2024; 25(4):589-596.

PMID: 38969937 DOI: 10.1007/s40368-024-00919-1.

The Relationship Between Periodontal Disease and Breast Cancer: From Basic Mechanism to Clinical Management and Prevention.

Zhang Y, Ren X, Hu T, Cheng R, Bhowmick N Oral Health Prev Dent. 2023; 21:49-60.

PMID: 36794777 PMC: 11619839. DOI: 10.3290/j.ohpd.b3904343.

Outpatient Dental Treatment Expenditure for Patients with Oromaxillofacial Cancer: A Cohort Study in Taiwan.

Ikbal M, Shen Y, Liang W, Wu T, Hsu J, Fuh L Int J Environ Res Public Health. 2022; 19(3).

PMID: 35162090 PMC: 8833949. DOI: 10.3390/ijerph19031066.

Oral Equilibrium in Cachexia.

Darwin D, Castelino R, Babu G, Asan M, Sarkar A, Shaktivel S Asia Pac J Oncol Nurs. 2021; 8(5):519-526.

PMID: 34527781 PMC: 8420925. DOI: 10.4103/apjon.apjon-2139.

References

Hong C, Hu S, Haverman T, Stokman M, Napenas J, Braber J . A systematic review of dental disease management in cancer patients. Support Care Cancer. 2017; 26(1):155-174. DOI: 10.1007/s00520-017-3829-y. View

Vale C, Burdett S, Rydzewska L, Albiges L, Clarke N, Fisher D . Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data. Lancet Oncol. 2016; 17(2):243-256. PMC: 4737894. DOI: 10.1016/S1470-2045(15)00489-1. View

Epstein J, Page J, Anderson G, Spinelli J . The role of an immunoperoxidase technique in the diagnosis of oral herpes simplex virus infection in patients with leukemia. Diagn Cytopathol. 1987; 3(3):205-9. DOI: 10.1002/dc.2840030306. View

Toljanic J, Bedard J, Larson R, Fox J . A prospective pilot study to evaluate a new dental assessment and treatment paradigm for patients scheduled to undergo intensive chemotherapy for cancer. Cancer. 1999; 85(8):1843-8. View

Vehmanen L, Suojanen J, Kontio R, Utriainen T, Blomqvist C . High frequency of osteonecrosis of the jaw among denosumab-treated prostate cancer patients. Acta Oncol. 2016; 56(1):104-106. DOI: 10.1080/0284186X.2016.1262548. View

Eastell R, Adams J, Coleman R, Howell A, Hannon R, Cuzick J . Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol. 2008; 26(7):1051-7. DOI: 10.1200/JCO.2007.11.0726. View

Van Poznak C, Temin S, Yee G, Janjan N, Barlow W, Biermann J . American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. J Clin Oncol. 2011; 29(9):1221-7. DOI: 10.1200/JCO.2010.32.5209. View

Taichman L, Van Poznak C, Inglehart M . Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis. Support Care Cancer. 2016; 24(11):4815-24. PMC: 5614704. DOI: 10.1007/s00520-016-3336-6. View

Lee I, Koom W, Lee C, Kim Y, Yoo S, Keum K . Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 2009; 75(4):1084-91. DOI: 10.1016/j.ijrobp.2008.12.052. View

10.

Schuurhuis J, Stokman M, Roodenburg J, Reintsema H, Langendijk J, Vissink A . Efficacy of routine pre-radiation dental screening and dental follow-up in head and neck oncology patients on intermediate and late radiation effects. A retrospective evaluation. Radiother Oncol. 2011; 101(3):403-9. DOI: 10.1016/j.radonc.2011.09.018. View

11.

Ogama N, Suzuki S . Adverse effects and appetite suppression associated with particle beam therapy in patients with head and neck cancer. Jpn J Nurs Sci. 2012; 9(1):28-37. DOI: 10.1111/j.1742-7924.2011.00180.x. View

12.

Ogama N, Suzuki S, Umeshita K, Kobayashi T, Kaneko S, Kato S . Appetite and adverse effects associated with radiation therapy in patients with head and neck cancer. Eur J Oncol Nurs. 2009; 14(1):3-10. DOI: 10.1016/j.ejon.2009.07.004. View

13.

Bressan V, Stevanin S, Bianchi M, Aleo G, Bagnasco A, Sasso L . The effects of swallowing disorders, dysgeusia, oral mucositis and xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: A systematic review. Cancer Treat Rev. 2016; 45:105-19. DOI: 10.1016/j.ctrv.2016.03.006. View

14.

Burstein H, Prestrud A, Seidenfeld J, Anderson H, Buchholz T, Davidson N . American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol. 2010; 28(23):3784-96. PMC: 5569672. DOI: 10.1200/JCO.2009.26.3756. View

15.

Raber-Durlacher J, Epstein J, Raber J, van Dissel J, van Winkelhoff A, Guiot H . Periodontal infection in cancer patients treated with high-dose chemotherapy. Support Care Cancer. 2002; 10(6):466-73. DOI: 10.1007/s00520-002-0346-3. View

16.

Chen J, Wang C, Wong Y, Wang C, Jiang R, Lin J . Osteoradionecrosis of mandible bone in patients with oral cancer--associated factors and treatment outcomes. Head Neck. 2014; 38(5):762-8. DOI: 10.1002/hed.23949. View

17.

Greenberg M, COHEN S, McKitrick J, Cassileth P . The oral flor as a source of septicemia in patients with acute leukemia. Oral Surg Oral Med Oral Pathol. 1982; 53(1):32-6. DOI: 10.1016/0030-4220(82)90483-2. View

18.

Saad F, Gleason D, Murray R, Tchekmedyian S, Venner P, Lacombe L . Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst. 2004; 96(11):879-82. DOI: 10.1093/jnci/djh141. View

19.

Lowenberg B, Downing J, Burnett A . Acute myeloid leukemia. N Engl J Med. 1999; 341(14):1051-62. DOI: 10.1056/NEJM199909303411407. View

20.

Hasegawa T, Kawakita A, Ueda N, Funahara R, Tachibana A, Kobayashi M . A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent.... Osteoporos Int. 2017; 28(8):2465-2473. DOI: 10.1007/s00198-017-4063-7. View